Anthropic進入藥物研發——AI能解決Big Pharma 12年的失敗率問題嗎？
anthropic啟動了針對被忽視疾病的內部藥物發現項目以訓練其ai，標誌著其進軍高風險生物學應用領域。
anthropic will conduct preclinical research for neglected diseases, citing its nonprofit mission and the need for complex training data to improve its ai models. the announcement accompanied the launch of 'claude science', a tool where a ucsf researcher reportedly used claude to identify a year-old viral contamination in minutes. this strategy aligns with broader industry efforts, such as google's isomorphic labs, to cut drug development timelines from 12 to 8 years.